News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
695,727 Results
Type
Article (39529)
Company Profile (247)
Press Release (655951)
Section
Business (204092)
Career Advice (2007)
Deals (35412)
Drug Delivery (94)
Drug Development (81001)
Employer Resources (172)
FDA (16149)
Job Trends (14842)
News (345023)
Policy (32495)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (1)
2024 BioForest Standard (1)
2024 BioMidwest Digital (7)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (4)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (17)
2024 Biotech Beach Digital (8)
2024 Biotech Beach Standard (4)
2024 Genetown Digital (5)
2024 Genetown Standard (9)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (5)
2024 Pharm Country Standard (5)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (5)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Standard (1)
Academia (2546)
Accelerated approval (2)
Adcomms (20)
Allergies (80)
Alliances (49362)
ALS (81)
Alzheimer's disease (1345)
Antibody-drug conjugate (ADC) (107)
Approvals (16150)
Artificial intelligence (225)
Autoimmune disease (13)
Automation (14)
Bankruptcy (360)
Best Places to Work (11636)
BIOSECURE Act (18)
Biosimilars (100)
Biotechnology (175)
Bladder cancer (56)
Brain cancer (24)
Breast cancer (245)
Cancer (1957)
Cardiovascular disease (147)
Career advice (1673)
Career pathing (29)
CAR-T (139)
Cell therapy (392)
Cervical cancer (17)
Clinical research (65643)
Collaboration (757)
Compensation (446)
Complete response letters (18)
COVID-19 (2580)
CRISPR (34)
C-suite (203)
Cystic fibrosis (98)
Data (1896)
Decentralized trials (2)
Denatured (16)
Depression (36)
Diabetes (241)
Diagnostics (6326)
Digital health (17)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (109)
Drug pricing (95)
Drug shortages (25)
Duchenne muscular dystrophy (84)
Earnings (86119)
Editorial (31)
Employer branding (21)
Employer resources (146)
Events (111568)
Executive appointments (626)
FDA (17234)
Featured Employer (47)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (681)
Gene editing (94)
Generative AI (18)
Gene therapy (270)
GLP-1 (677)
Government (4377)
Grass and pollen (4)
Guidances (48)
Healthcare (18802)
Huntington's disease (22)
IgA nephropathy (21)
Immunology and inflammation (101)
Indications (26)
Infectious disease (2708)
Inflammatory bowel disease (131)
Inflation Reduction Act (8)
Influenza (46)
Intellectual property (83)
Interviews (311)
IPO (16484)
IRA (40)
Job creations (3628)
Job search strategy (1422)
Kidney cancer (9)
Labor market (34)
Layoffs (448)
Leadership (15)
Legal (7899)
Liver cancer (70)
Lung cancer (287)
Lymphoma (129)
Machine learning (2)
Management (58)
Manufacturing (264)
MASH (59)
Medical device (13312)
Medtech (13317)
Mergers & acquisitions (19391)
Metabolic disorders (619)
Multiple sclerosis (67)
NASH (16)
Neurodegenerative disease (75)
Neuropsychiatric disorders (24)
Neuroscience (1805)
NextGen: Class of 2025 (6511)
Non-profit (4476)
Northern California (2384)
Now hiring (37)
Obesity (336)
Opinion (201)
Ovarian cancer (71)
Pain (75)
Pancreatic cancer (76)
Parkinson's disease (130)
Partnered (18)
Patents (199)
Patient recruitment (93)
Peanut (46)
People (57045)
Pharmaceutical (63)
Pharmacy benefit managers (18)
Phase I (20443)
Phase II (28908)
Phase III (21541)
Pipeline (959)
Podcasts (44)
Policy (107)
Postmarket research (2563)
Preclinical (8648)
Press Release (64)
Prostate cancer (91)
Psychedelics (30)
Radiopharmaceuticals (243)
Rare diseases (350)
Real estate (5900)
Recruiting (65)
Regulatory (22107)
Reports (46)
Research institute (2316)
Resumes & cover letters (349)
Rett syndrome (3)
RNA editing (2)
RSV (37)
Schizophrenia (61)
Series A (120)
Series B (77)
Service/supplier (11)
Sickle cell disease (49)
Southern California (2058)
Special edition (14)
Spinal muscular atrophy (147)
Sponsored (28)
Startups (3571)
State (2)
Stomach cancer (12)
Supply chain (59)
The Weekly (25)
United States (20830)
Vaccines (652)
Venture capitalists (37)
Webinars (12)
Weight loss (224)
Women's health (33)
Worklife (15)
Date
Last 7 days (564)
Last 30 days (2476)
Last 365 days (33466)
2025 (7624)
2024 (35218)
2023 (40076)
2022 (51173)
2021 (55710)
2020 (54083)
2019 (46538)
2018 (35018)
2017 (32109)
2016 (31480)
2015 (37552)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (717)
Alabama (49)
Alaska (7)
Arizona (223)
Arkansas (13)
Asia (37681)
Australia (6160)
California (5436)
Canada (1853)
China (465)
Colorado (244)
Connecticut (256)
Delaware (123)
Europe (80789)
Florida (809)
Georgia (190)
Idaho (57)
Illinois (488)
India (23)
Indiana (288)
Iowa (9)
Japan (138)
Kansas (100)
Kentucky (23)
Louisiana (7)
Maine (60)
Maryland (822)
Massachusetts (4085)
Michigan (208)
Minnesota (366)
Mississippi (2)
Missouri (75)
Montana (27)
Nebraska (25)
Nevada (56)
New Hampshire (62)
New Jersey (1545)
New Mexico (28)
New York (1560)
North Carolina (908)
North Dakota (7)
Northern California (2384)
Ohio (190)
Oklahoma (14)
Oregon (33)
Pennsylvania (1237)
Puerto Rico (9)
Rhode Island (26)
South America (1094)
South Carolina (18)
South Dakota (1)
Southern California (2058)
Tennessee (92)
Texas (809)
Utah (163)
Virginia (127)
Washington D.C. (57)
Washington State (506)
West Virginia (3)
Wisconsin (48)
695,727 Results for "vaccinex inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Pharm Country
Vaccinex, Inc. Announces Reverse Stock Split - February 15, 2024
Vaccinex, Inc. announced that it will effect a 1-for-14 reverse stock split of its issued common stock, effective at 5:00 p.m. Eastern Time on Monday, February 19, 2024.
February 15, 2024
·
6 min read
Business
Vaccinex Reports 2023 Financial Results and Provides Corporate Update
Vaccinex, Inc. today announced financial results for the fourth quarter ended December 31, 2023 and provided a corporate update on key programs.
April 2, 2024
·
11 min read
Business
Vaccinex Reports First Quarter 2024 Financial Results and Provides Corporate Update
Vaccinex, Inc., a clinical-stage biotechnology company pioneering a differentiated approach to treating neurodegenerative disease and cancer through the inhibition of Semaphorin 4D, announced financial results for the first quarter ended March 31, 2024, and provided a corporate update on its key program for Alzheimer’s disease.
May 15, 2024
·
13 min read
Pharm Country
Vaccinex Reports Completion of Last Patient Visit in Randomized, SIGNAL-AD Phase 1b/2 Study of Pepinemab Treatment for Alzheimer’s Disease
Vaccinex, Inc. today announced that the last patient completed their last visit in its randomized, placebo-controlled double-blind study of pepinemab treatment for Alzheimer’s disease.
June 6, 2024
·
7 min read
Press Releases
Vaccinex Reports Third Quarter 2024 Financial Results and Provides Corporate Update
November 18, 2024
·
14 min read
Press Releases
Vaccinex Provides Update on ActivMAb® Platform: Multiple Project Deals and Presentation at SITC
November 8, 2024
·
6 min read
Pharm Country
Vaccinex, Inc. Announces $1.5 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules
Vaccinex, Inc. announced that it has entered into definitive agreements with certain institutional investors for the purchase and sale of 193,000 shares of its common stock in a registered direct offering together with warrants to purchase up to an aggregate of 193,000 shares of common stock in a concurrent private placement priced at-the-market under Nasdaq rules at a combined purchase price of $7.77 per share and accompanying warrant.
March 27, 2024
·
4 min read
Business
Vaccinex Announces Multiple New Agreements for Access to ActivMAb® Antigen Virus Technology
Vaccinex, Inc. (Nasdaq: VCNX) announces that it has entered into eight new antibody discovery agreements integrating use of its proprietary ActivMAb platform to select antibodies against difficult-to-drug transmembrane protein targets.
February 21, 2024
·
5 min read
Pharm Country
Vaccinex Announces Pricing of $3.7 Million PIPE Financing
Vaccinex, Inc. announced it has priced a $3.7 million private placement transaction with a lead investment from a major new investor alongside significant participation from existing investors, including entities affiliated with the Chairman of the Company’s Board of Directors and the Company’s Chief Executive Officer.
February 7, 2024
·
6 min read
Pharm Country
Vaccinex, Inc. Announces Reverse Stock Split
Vaccinex, Inc., a clinical-stage biotechnology company pioneering a differentiated approach to treating neurodegenerative disease and cancer through the inhibition of SEMA4D, announced that it will effect a 1-for-15 reverse stock split of its issued common stock, effective at 5:00 p.m. Eastern Time on Monday, September 25, 2023.
September 22, 2023
·
6 min read
1 of 69,573
Next